News Quantified

SOPH – sophia genetics sa - ordinary shares (US:NASDAQ)

Looking At The Narrative For SOPHiA GENETICS After The Latest Price Target Shift [Yahoo! Finance]

1/26

10:02 am

soph

Low

SOPHiA GENETICS (NASDAQ:SOPH) had its "buy" rating reaffirmed by analysts at Guggenheim.

SOPHiA GENETICS (NASDAQ:SOPH) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan

SOPHiA GENETICS verstrekt voorlopige financiële resultaten voor het vierde kwartaal en het volledige jaar 2025, geeft richtsnoeren voor 2026 en kondigt overgangsplan voor de directie aan

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}